Francesca Arena

A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study

Angioletta Lasagna, Francesco Agustoni, Elena Percivalle et al. · ESMO Open · 2021 · 43 citations · Full text

Medicine, Immunology, Oncology +17

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients

Irene Cassaniti, Marilena Gregorini, Federica Bergami et al. · Vaccines · 2022 · 30 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects

Josè Camilla Sammartino, Irene Cassaniti, Alessandro Ferrari et al. · Journal of Medical Virology · 2023 · 29 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study

Angioletta Lasagna, Federica Bergami, Daniele Lilleri et al. · ESMO Open · 2022 · 24 citations · Full text

Veterinary Medicine, Immunology, Oncology +17

Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up

Angioletta Lasagna, Daniele Lilleri, Francesco Agustoni et al. · ESMO Open · 2021 · 19 citations · Full text

Medicine, Immunology, Oncology +17